Physician profile
Lawrence E Simpson
NPI 1982611786
$2,986.05
in general payments reported to CMS, 2019-2025
22 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $336 · 2021: $920 · 2022: $685 · 2023: $245 · 2024: $149 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $506.49 | 2019-2025 | |
| Amgen INC. | $479.79 | 2019-2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $393.12 | 2019-2023 | Jardiance |
| Pfizer INC. | $343.03 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $213.70 | 2021-2024 | Xarelto |
| Esperion Therapeutics, INC. | $152.69 | 2020-2025 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $113.32 | 2021-2025 | Eliquis |
| Amarin Pharma, INC. | $99.00 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $89.00 | 2021-2022 | |
| Abbott Laboratories | $88.17 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $82.15 | 2020-2022 | |
| Inspire Medical Systems, INC. | $81.02 | 2024-2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $69.61 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $61.55 | 2019-2022 | |
| Bracco Diagnostics INC. | $37.65 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $37.22 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.28 | 2021 | |
| Arbor Pharmaceuticals, INC. | $30.01 | 2019-2020 | |
| Edwards Lifesciences Corporation | $27.95 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Heartflow, INC. | $18.60 | 2022 | |
| Medtronic Vascular, INC. | $16.03 | 2019 | |
| Allergan, INC. | $13.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.